RoboCT
程天科技
RoboCT (程天科技) is a Chinese exoskeleton company positioned as a domestic industry leader in rehabilitation robotics . It has developed a self-contained technical system that enables disruptive cost-structure innovation at the clinical-product level , and multiple rehabilitation and robotics products have received U.S. FDA certification . The company originated in the medical-grade exoskeleton space and is now expanding into the consumer exoskeleton market, where it competes with firms like Hypershell Tech . BlueRun Ventures was the sole investor in its Series A and also participated in its Series A+ .
AI-generated — may contain errors, please verify.
Coverage
Into Reality, a New Odyssey for Robots | BlueRun Ventures' WRC Observations
Chinese robotics entrepreneurs are writing a new narrative for robots.
BlueRun Ventures Leads Round as SiClink Focuses on Visual Reconstruction, Exploring New Frontiers in Brain-Computer Interfaces | BlueRun Portfolio
Bidirectional interaction is the critical turning point that transforms brain-computer interfaces from "functional compensation tools" into "information interfaces."
BlueRun Ventures Portfolio Company Puyu Technology Closes Hundreds of Millions of RMB Financing to Accelerate Nanoimprint Lithography Equipment Commercialization | BlueRun Family
Opening a New Front for China's Semiconductor Breakthrough
BlueRun Ventures Portfolio Company Tian Cheng Technology Closes Another 100-Million-Yuan B+ Round to Accelerate the "Human-Machine Fusion" Era of Exoskeleton Consumerization | BlueRun Family
Making the leap from "rehabilitation tool" to "enhancement partner."
Hypershell Closes Two Rounds Totaling $70 Million in Funding
Toward a Future Where Everyone Is "Iron Man"?
They Talk, We Create | Quarterly
The evening breeze of a summer night is the sound of the future rushing in.
Welcome to Register: 2025 World Robot Conference Project Roadshow and Investment-Matching Session | BlueRun Ventures × Shoucheng Capital
Face to Face with a Robot
Planting Spring in the Wind | Quarterly
On the Move
Tian Cheng Technology Closes Nearly 100 Million RMB Series B Round to Accelerate Global Expansion of Embodied Intelligence Exoskeletons | BlueRun Family
Technology should serve everyone.
Birds Fly Over the Harsh Winter | Monthly
Spring mountains within sight, the future there to climb.
BlueRun Ventures and Ant Group Are Looking for the Most Hardcore Deep-Tech Founders — Is That You? | Registration Closing Soon
From barely a peep to booming — come aboard!
SRO! How Embodied Intelligence Tech Is Going Industrial, From the BlueRun Ventures Forum at the World Robot Conference
From the Lab to the Real World
9 Days to Go! World Robot Conference × BlueRun Ventures | General-Purpose Robotics and Embodied AI Frontier Technology Industrialization Forum Set to Debut
Embracing the Era of General-Purpose Robots Together
Breaking Through Your Mental Block in an Olympic Year | BlueRun Ventures Bi-Monthly Report
OUVRONS GRAND LES JEUX This text is already in French, not Chinese. It translates to English as: **LET THE GAMES BEGIN** Or more literally: "Let's open the games wide" / "Let the games open grandly" (This is the official slogan/tagline for the Paris 2024 Olympic and Paralympic Games.)
Early Summer, Time to Surf to Your Heart's Content! | BlueRun Ventures Bi-Monthly Report
The thrill of surfing freely under a blazing sun.
BlueRun Ventures Portfolio Companies Named to 2024 Future Healthcare 100 List
Continuously searching for next-generation biotech companies that align with industry logic
The Best Time of Spring | February & March Bi-Monthly Report
Though it goes unnoticed, new life is already quietly taking root.
The Future Looks Very Different | December & January Bimonthly Report
Witnessing BlueRun Ventures' "Defining Moment"
BlueRun Ventures Quarterly Investment & Financing Overview | 2023 Q4
Sector distribution spans artificial intelligence, enterprise services, hard tech, and biotech, among others.
Looking at the Other Side of the Coin | October & November Report
Grateful for what life has given
No Matter How Far, We Can Get There | August & September Bi-Monthly Report
Go Far Away
Tian Cheng Technology Secures Investment from Pappas Capital, Focusing on Exoskeleton Robotics for Tech-Enabled Elderly Care | BlueRun Ventures
Ranked first globally in both the number of rehabilitation exoskeletons deployed and in active use
Surging Waves, Endless Ascent | June Report
Go all in, or don't join at all.
The Road to AGI | Supercharged by Large Models, Robotics Is Entering a New Era
What unresolved problems will it solve for intelligent systems?
Multiple BlueRun Ventures portfolio companies named to 2023 Future Healthcare 100 list
Standing by founders from 0 to 1 to redefine the future.
Jui Chan, BlueRun Ventures: Riding the Waves — Don't Waste a Crisis | BlueRun Perspectives
Adaptability is the eternal question for investors.
You Can't Predict. You Can Prepare | April Report
Riding the Unpredictable Wave
Be the change we want to see | BlueRun Ventures December Report
Memorable Moments from December
